Spots Global Cancer Trial Database for Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
Official Title: Long-term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
Study ID: NCT04577742
Interventions
Study Description
Brief Summary: This study investigated the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020
Detailed Description:
Keywords
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Naples "Federico II", Naples, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
